AIDS in Africa
For the past two decades multinational drug companies have turned a blind eye on the AIDS epidemic in South Africa by refusing to sell antiretroviral drugs to them at discounted prices. The antiretroviral drugs are the standard virus treatment available to AIDS patients in the United States and other developed nations. The cost for the treatment runs between $10,000 and 15,000 per patient per year. The high cost of the drugs makes it virtually impossible for South Africans to afford it when their average income is less than $500 per year. There are more than 25 million people in sub-Saharan Africa infected with the HIV virus that causes AIDS. Last year 2.4 million South Africans died from the disease. Many were babies and teenagers, which are the most vulnerable of the population. The epidemic, which was once viewed as “being so large it defied a solution”, has now reached pandemic proportions. Every man, woman, and child is either effected or affected with this deadly disease. However, due to increasing public awareness regarding the high price of the drugs and the intense pressures from advocacy groups across the globe to lower them, the tides are beginning to turn. In the last six months 39 mu
Contrary to the belief of the drug companies, the responsibility of conquering the AIDS epidemic in South Africa will be a shared endeavor. Lowering the price of the drugs is only the first step in this war against AIDS. The next step is figuring out how to pay for them. Secretary General Kofi Annan has proposed a global fund be established to fight AIDS and other infectious diseases. The largest contributions would have to come from governments of wealthy nations, non-government organizations, and the private sector worldwide. (Crosette A1) The agreement of the global drug companies to sell their products at discounted prices will put less of a financial burden on the governments of underdeveloped nations as well as developed nations financing the fund. The agreement of the 39 multinational drug companies to lower the cost of antiretroviral drugs in South Africa is the first positive step toward eradicating the deadly plague, which has engulfed the country. South Africa can now offer it’s citizen hope that one day they will be able to live their lives free from the threat of contracting the HIV virus that causes AIDS. This turn of events is due in part to the role the media has played in educating the public about the high cost of the drugs and the refusal of the drug companies to lower the prices. Also, the international spotlight has brought the images of the millions of Africans dying from lack of drugs in make shift metal shacks and over crowded hospitals to the forefront of the American conscious and the world. (Stolberg A1) Another valid reason why drug companies have opposed selling their drugs at discounted prices has been to protect their patent rights. Patents entitle drug companies array of privileges. It allows them to market their drug for a specific amount of time, usually 20 years, without competition from other drug companies or other generic drug companies. They can also set the price of the drug as they see fit. The patent justifies the high cost of drugs because it can sometimes take more th
Some topics in this essay:
South Africa,
South Africans,
White Act,
Africa’s Asia’s,
Crosette A1,
drug companies,
Kofi Annan,
A1 United,
African AIDS,
Prusoff A19,
south africa,
Drug Administration,
antiretroviral drugs,
discounted prices,
drugs discounted,
drugs discounted prices,
aids epidemic,
aids epidemic south,
aids drugs,
united developed,
south africans,
cost drugs,
epidemic south africa,
multinational drug companies,
hiv virus causes,
Join now to see the rest of the essay!
Approximate Word count = 1391
Approximate Pages = 6 (250 words per page double spaced)
More Essays on AIDS in Africa Professional Papers: |
CUSTOMER SERVICES
|
|
Saved Papers
You haven't saved any papers.
|